LYFULYST Trademark

Trademark Overview


On Thursday, March 10, 2016, a trademark application was filed for LYFULYST with the United States Patent and Trademark Office. The USPTO has given the LYFULYST trademark a serial number of 86935472. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 21, 2019. This trademark is owned by Eli Lilly and Company. The LYFULYST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
lyfulyst

General Information


Serial Number86935472
Word MarkLYFULYST
Filing DateThursday, March 10, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 21, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, October 21, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 21, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, February 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 7, 2019EXTENSION 5 GRANTED
Tuesday, February 5, 2019EXTENSION 5 FILED
Tuesday, February 5, 2019TEAS EXTENSION RECEIVED
Saturday, August 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 17, 2018EXTENSION 4 GRANTED
Wednesday, August 15, 2018EXTENSION 4 FILED
Wednesday, August 15, 2018TEAS EXTENSION RECEIVED
Tuesday, February 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 23, 2018EXTENSION 3 GRANTED
Friday, February 23, 2018EXTENSION 3 FILED
Friday, February 23, 2018TEAS EXTENSION RECEIVED
Saturday, August 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 18, 2017EXTENSION 2 GRANTED
Wednesday, August 16, 2017EXTENSION 2 FILED
Wednesday, August 16, 2017TEAS EXTENSION RECEIVED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 10, 2017EXTENSION 1 GRANTED
Monday, February 6, 2017EXTENSION 1 FILED
Wednesday, February 8, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 6, 2017TEAS EXTENSION RECEIVED
Tuesday, September 20, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 15, 2016ASSIGNED TO EXAMINER
Tuesday, March 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 14, 2016NEW APPLICATION ENTERED IN TRAM